Opportunity Information: Apply for RFA DA 15 013
Apply for RFA DA 15 013
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Integration of Infectious Diseases and Substance Abuse Intervention Services for Individuals Living with HIV (R01)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.279 Drug Abuse and Addiction Research Programs.
- This funding opportunity was created on Jan 8, 2015 and posted on Jan 8, 2015.
- Applicants must submit their applications by Apr 14, 2015. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $3,000,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $3,000,000.00 in funding.
- Eligible applicants include: Private institutions of higher education Others (see text field entitled Additional Information on Eligibility for clarification) Special district governments City or township governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Small businesses For profit organizations other than small businesses Native American tribal governments (Federally recognized) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Independent school districts County governments Public and State controlled institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) State governments Public housing authorities/Indian housing authorities.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Asian American Native American Pacific Islander Serving Institutions (AANAPISISs) Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Non domestic (non U.S.) Entities (Foreign Organizations) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession Non domestic (non U.S.) Entities (Foreign Institutions) are eligible to apply. Non domestic (non U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The National Institutes of Health (NIH) offered this discretionary grant opportunity, Funding Opportunity Number RFA-DA-15-013, titled "Integration of Infectious Diseases and Substance Abuse Intervention Services for Individuals Living with HIV (R01)." It uses the R01 research project grant mechanism and falls under CFDA 93.279 (Drug Abuse and Addiction Research Programs). The core aim of the announcement is to fund research that goes beyond individual-level clinical interventions and instead develops and tests organizational- and systems-level strategies for delivering more comprehensive care. The emphasis is on figuring out the most effective ways to provide integrated, high-quality, sustainable, and cost-effective services that improve health outcomes for people living with HIV (PLWH) who also have substance use disorders and other common co-occurring conditions.
The opportunity prioritizes two main research directions. First, it supports multidisciplinary projects that improve the adoption and integration of evidence-based substance use screening and treatment within HIV centers and closely connected medical settings. In practical terms, this means studying how HIV care sites can reliably incorporate proven approaches for identifying substance use problems, initiating or coordinating treatment, and maintaining those services as part of routine HIV care workflows. Second, it supports multidisciplinary projects that increase the adoption and integration of HIV testing and effective linkage to HIV care within addiction treatment settings. That strand targets the reverse integration problem: ensuring that people receiving addiction services are routinely offered HIV testing, and that those who test positive are efficiently connected to HIV medical care and retained in it.
Across both HIV care environments and addiction treatment environments, the FOA also encourages research that strengthens the integration of services for comorbid conditions that frequently complicate care. The announcement specifically mentions coinfections and psychiatric disorders as examples, reflecting a broader interest in models that recognize the real-world complexity of patients who may be navigating HIV, substance use, mental health needs, and other infectious or chronic conditions simultaneously. The underlying theme is implementation at scale: how organizations, clinics, and systems can adopt evidence-based practices, coordinate across service silos, and sustain integrated care in ways that measurably improve outcomes.
From a funding and administrative standpoint, the estimated total funding amount listed is $3,000,000, and the award ceiling is also $3,000,000. The posted and creation date for the opportunity was January 8, 2015, with an original and current closing date of April 14, 2015, and an archive date of May 15, 2015. There is no cost sharing or matching requirement. The activity categories include education and health, consistent with NIH support for applied health services and implementation-oriented research.
Eligibility is broad and includes public and private institutions of higher education, nonprofits (including both 501(c)(3) and non-501(c)(3) organizations), for-profit organizations, small businesses, and a wide range of governmental entities (state, county, city/township, special districts, and certain housing authorities). The eligibility language also extends to a range of specific institution types and community-focused organizations, including faith-based and community-based organizations, Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, tribally controlled colleges and universities, and other minority-serving institutions. Importantly, non-U.S. entities and foreign institutions are eligible to apply, non-U.S. components of U.S. organizations are eligible, and foreign components (as defined by NIH policy) are allowed, signaling that NIH was open to international participation where scientifically justified.
The sponsoring agency is NIH, and additional details were provided through the NIH Grants Guide link associated with the RFA. For technical difficulties accessing the full announcement, the contact listed is the NIH Office of Extramural Research (OER) webmaster at FBOWebmaster@OD.NIH.GOV.
Frequently Asked Questions (FAQs)
What is the funding opportunity number and title?
The funding opportunity is NIH Funding Opportunity Number (FON) RFA-DA-15-013, titled "Integration of Infectious Diseases and Substance Abuse Intervention Services for Individuals Living with HIV (R01)."
Which agency is sponsoring this grant opportunity?
The sponsoring agency is the National Institutes of Health (NIH).
What grant mechanism is used for this opportunity?
This opportunity uses the R01 Research Project Grant mechanism.
What CFDA number is associated with this opportunity?
The opportunity is listed under CFDA 93.279, Drug Abuse and Addiction Research Programs.
What is the main goal of this funding opportunity?
The core goal is to fund research that develops and tests organizational- and systems-level strategies to deliver more comprehensive care for people living with HIV (PLWH) who also have substance use disorders and other common co-occurring conditions. The focus is on identifying effective ways to provide integrated, high-quality, sustainable, and cost-effective services that improve health outcomes.
Does the FOA focus on individual-level clinical interventions?
No. The announcement emphasizes research that goes beyond individual-level clinical interventions and instead targets organizational and system implementation strategies.
What types of service integration does the opportunity prioritize?
The opportunity prioritizes two main directions: (1) integrating evidence-based substance use screening and treatment into HIV care settings, and (2) integrating HIV testing and effective linkage to HIV care into addiction treatment settings.
What does integration within HIV care settings mean in this FOA?
It means studying how HIV centers and closely connected medical settings can adopt, implement, and sustain evidence-based substance use screening and treatment as part of routine HIV care workflows, including reliably identifying substance use problems, initiating or coordinating treatment, and maintaining those services over time.
What does integration within addiction treatment settings mean in this FOA?
It means ensuring that people receiving addiction services are routinely offered HIV testing, and that individuals who test positive are efficiently linked to HIV medical care and retained in care.
Is multidisciplinary research expected or encouraged?
Yes. The FOA explicitly supports multidisciplinary projects in both priority research directions.
What outcomes is the FOA trying to improve?
The emphasis is on improving health outcomes for PLWH with substance use disorders through integrated, high-quality, sustainable, and cost-effective service delivery models.
Does the FOA encourage integration of services for other comorbid conditions?
Yes. Across both HIV care and addiction treatment environments, the FOA encourages research that strengthens integration of services for co-occurring conditions that commonly complicate care.
Which comorbid conditions are specifically mentioned?
The announcement specifically mentions coinfections and psychiatric disorders as examples of comorbidities relevant to integrated service models.
Is the FOA focused on implementation at scale?
Yes. A central theme is implementation at scale: how organizations, clinics, and systems adopt evidence-based practices, coordinate across service silos, and sustain integrated care models in ways that measurably improve outcomes.
What is the estimated total funding amount for this opportunity?
The estimated total funding amount listed is $3,000,000.
What is the award ceiling?
The award ceiling is $3,000,000.
Is there a cost sharing or matching requirement?
No. The opportunity states that there is no cost sharing or matching requirement.
What are the activity categories for this funding opportunity?
The activity categories include education and health.
When was this opportunity posted?
The posted (and creation) date for the opportunity was January 8, 2015.
What was the closing date for applications?
The original and current closing date listed is April 14, 2015.
When was the opportunity archived?
The archive date is May 15, 2015.
Who is eligible to apply?
Eligibility is broad. It includes public and private institutions of higher education; nonprofits (including both 501(c)(3) and non-501(c)(3) organizations); for-profit organizations; small businesses; and a wide range of governmental entities such as state, county, city/township, special district governments, and certain housing authorities.
Are community-based or faith-based organizations eligible?
Yes. The eligibility description explicitly includes faith-based and community-based organizations.
Are minority-serving institutions eligible?
Yes. The eligibility language includes Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, tribally controlled colleges and universities, and other minority-serving institutions.
Are non-U.S. organizations eligible to apply?
Yes. Non-U.S. entities and foreign institutions are eligible to apply.
Are non-U.S. components of U.S. organizations allowed?
Yes. The opportunity indicates that non-U.S. components of U.S. organizations are eligible.
Are foreign components allowed under NIH policy?
Yes. Foreign components (as defined by NIH policy) are allowed.
Where can applicants find additional details about the announcement?
Additional details were provided through the NIH Grants Guide link associated with the RFA.
Who should be contacted for technical difficulties accessing the full announcement?
For technical difficulties accessing the full announcement, the listed contact is the NIH Office of Extramural Research (OER) webmaster at FBOWebmaster@OD.NIH.GOV.
Browse more opportunities from the same agency: National Institutes of Health
Browse more opportunities from the same category: Education Health
Next opportunity: Predictive Multiscale Models for Biomedical, Biological, Behavioral, Environmental and Clinical Research (U01)
Previous opportunity: NIDCR Dentist Scientist Career Transition Award for Intramural Investigators (K22)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA DA 15 013
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA DA 15 013) also looked into and applied for these:
| Funding Opportunity |
|---|
| Cutting Edge Basic Research Awards (CEBRA) (R21) Apply for PAR 15 079 Funding Number: PAR 15 079 Agency: National Institutes of Health Category: Education Health Funding Amount: $125,000 |
| Innovative Molecular Analysis Technologies for Cancer Research (R21) Apply for RFA CA 15 002 Funding Number: RFA CA 15 002 Agency: National Institutes of Health Category: Education Health Funding Amount: $2,000,000 |
| Innovative Technologies for Cancer Relevant Biospecimen Science (R21) Apply for RFA CA 15 004 Funding Number: RFA CA 15 004 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Advanced Development and Validation of Emerging Molecular Analysis Technologies for Cancer Research (R33) Apply for RFA CA 15 003 Funding Number: RFA CA 15 003 Agency: National Institutes of Health Category: Education Health Funding Amount: $300,000 |
| Advanced Development and Validation of Emerging Technologies for Cancer Relevant Biospecimen Science (R33) Apply for RFA CA 15 005 Funding Number: RFA CA 15 005 Agency: National Institutes of Health Category: Education Health Funding Amount: $300,000 |
| Drug Abuse Prevention Intervention Research (R21) Apply for PA 15 080 Funding Number: PA 15 080 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Drug Abuse Prevention Intervention Research (R03) Apply for PA 15 081 Funding Number: PA 15 081 Agency: National Institutes of Health Category: Education Health Funding Amount: $50,000 |
| Drug Abuse Prevention Intervention Research (R01) Apply for PA 15 082 Funding Number: PA 15 082 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| BRAIN Initiative Development, Optimization, and Validation of Novel Tools and Technologies for Neuroscience Research (STTR) (R41/R42) Apply for PAR 15 090 Funding Number: PAR 15 090 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| BRAIN Initiative Development, Optimization, and Validation of Novel Tools and Technologies for Neuroscience Research (SBIR) (R43/R44) Apply for PAR 15 091 Funding Number: PAR 15 091 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Exploratory/Developmental Grants Program for Basic Cancer Research in Cancer Health Disparities (R21) Apply for PAR 15 092 Funding Number: PAR 15 092 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Basic Cancer Research in Cancer Health Disparities (R01) Apply for PAR 15 093 Funding Number: PAR 15 093 Agency: National Institutes of Health Category: Education Health Funding Amount: $250,000 |
| NIDA Translational Avant Garde Award for Development of Medication to Treat Substance Use Disorders (UH2/UH3) Apply for RFA DA 15 017 Funding Number: RFA DA 15 017 Agency: National Institutes of Health Category: Education Health Funding Amount: $1,000,000 |
| Assay Validation For High Quality Markers For NCI Supported Clinical Trials (UH2/UH3) Apply for PAR 15 095 Funding Number: PAR 15 095 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Assay Validation For High Quality Markers For NCI Supported Clinical Trials (UH3) Apply for PAR 15 096 Funding Number: PAR 15 096 Agency: National Institutes of Health Category: Education Health Funding Amount: $250,000 |
| Prevention Research in Mid Life Adults (R21) Apply for PA 15 097 Funding Number: PA 15 097 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Prevention Research in Mid Life Adults (R01) Apply for PA 15 098 Funding Number: PA 15 098 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Reductions in Illicit Drug Use and Functional Outcomes (R21/R33) Apply for PA 15 099 Funding Number: PA 15 099 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Maternal Nutrition and Pre pregnancy Obesity Effects on Mothers, Infants and Children (R01) Apply for PA 15 100 Funding Number: PA 15 100 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Core Infrastructure and Methodological Research for Cancer Epidemiology Cohorts (U01) Apply for PAR 15 104 Funding Number: PAR 15 104 Agency: National Institutes of Health Category: Education Health Funding Amount: $2,500,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA DA 15 013", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.